SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

King Brian Douglas

(Last)

(First)

(Middle)

C/O COVIDIEN

15 HAMPSHIRE STREET

(Street)

MANSFIELD

02048

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/21/2013

3. Issuer Name and Ticker or Trading Symbol
Covidien plc [ COV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Vice President

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	26,795⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽²⁾	11/30/2020	Ordinary Shares	15,120	$42.94	D
Stock Option (Right to Buy)	⁽³⁾	11/30/2021	Ordinary Shares	26,445	$46.45	D
Stock Option (Right to Buy)	⁽⁴⁾	11/30/2019	Ordinary Shares	6,405	$47.6	D
Stock Option (Right to Buy)	⁽⁵⁾	12/02/2022	Ordinary Shares	31,205	$57.57	D

Explanation of Responses:

1. Includes 9,069 Restricted Stock Units (RSU) which generally vest in equal installments on the first, second, third and fourth anniversary of the grant date and are settled in ordinary shares upon vesting. The Reporting Person will receive dividend equivalent stock units in connection with the RSUs.

2. This option becomes exercisable in two equal installments on each of December 1, 2013 and December 1, 2014.

3. This option becomes exercisable in three equal installments on each of December 1, 2013, December 1, 2014 and December 1, 2015.

4. This option becomes exercisable in full on December 1, 2013.

5. This option becomes exercisable in four equal installments on each of the first, second, third and fourth anniversary of the grant date, December 3, 2012.

Remarks:

kingpoa.txt

	By: John W. Kapples, Attorney in Fact	03/28/2013
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.